Metformin (MF) in the prevention of hyperglycemia (HG) in patients (pts) with PIK3CA-mutated, hormone receptor (HR) [+]/HER2[-] advanced breast cancer (ABC) treated with alpelisib (ALP) plus fulvestrant (F): METALLICA
No Thumbnail Available
Identifiers
Date
2021-05-08
Authors
Llombart Cussac, A.
Perez-Garcia, J. M.
Blanch, S.
Tolosa, P.
Ruiz Borrego, M.
Gion Cortes, M.
Fernadez, A.
Urruticoechea, A.
Galve, E.
Cueva Banuelos, J. F.
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Elsevier